Streetbeat News

Analyst Ratings

IFF

Goldman Sachs analyst Adam Samuelson has maintained a 'Buy' rating on Intl Flavors & Fragrances (IFF) but lowered the price target from $134 to $120.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2023 | 1:04 pm

EL

Goldman Sachs analyst Jason English has maintained a 'Buy' rating on Estee Lauder Cos (NYSE:EL) but lowered the price target from $266 to $238.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2023 | 1:02 pm

SQ

Over the past 3 months, 17 analysts have published their opinion on Block (NYSE:SQ) stock. The company has an average price target of $86.29, representing a 11.67% decrease from the previous average price target of $97.69. The majority of the analysts are somewhat bullish on the stock.

Portfolio Pulse from Benzinga Insights

July 18, 2023 | 1:01 pm

ENPH

Goldman Sachs analyst Brian Lee has maintained a 'Buy' rating on Enphase Energy (NASDAQ:ENPH) but lowered the price target from $285 to $250.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2023 | 1:01 pm

AIRC

Analysts have provided various ratings for Apartment Income REIT (NYSE:AIRC) within the last quarter, with 2 bullish, 1 somewhat bullish, and 1 indifferent. The average 12-month price target for AIRC is $40.75, a 0.61% decrease from the previous average price target of $41.00.

Portfolio Pulse from Benzinga Insights

July 18, 2023 | 1:01 pm

APLS

Over the past 3 months, 10 analysts have published their opinion on Apellis Pharmaceuticals (NASDAQ:APLS) stock. The analysts have an average price target of $102.4 versus the current price of Apellis Pharmaceuticals at $52.46, implying an upside. This current average has increased by 16.55% from the previous average price target of $87.86.

Portfolio Pulse from Benzinga Insights

July 18, 2023 | 1:01 pm

BBIO

Over the past 3 months, 4 analysts have published their opinion on BridgeBio Pharma (NASDAQ:BBIO) stock. The average 12-month price target for the stock is $39.5, with a high of $50.00 and a low of $29.00. This average price target has increased by 50.48% over the past month.

Portfolio Pulse from Benzinga Insights

July 18, 2023 | 1:01 pm

JBHT

J.B. Hunt Transport Services, Inc. (NASDAQ:JBHT) is expected to report lower Q2 earnings at $1.92 per share, down from $2.42 per share a year ago. The company's revenue is projected to be $3.31 billion. The company's shares rose 0.1% to close at $183.38 on Monday. Several analysts have recently adjusted their price targets for the company, with most seeing an upside of 6-9% in the stock.

Portfolio Pulse from Lisa Levin

July 18, 2023 | 1:00 pm

CE

14 analysts have provided ratings for Celanese (NYSE:CE) over the last quarter, with an average price target of $123.43, implying an upside from the current price of $121.04. The current average has decreased by 5.27% from the previous average price target of $130.30.

Portfolio Pulse from Benzinga Insights

July 18, 2023 | 1:00 pm

IMVT

Over the past 3 months, 9 analysts have published their opinion on Immunovant (NASDAQ:IMVT) stock. The average price target for the stock is $26.67, an increase of 1.29% from the previous average price target of $26.33. Out of the 9 analysts, 8 have given a bullish rating while 1 has given a somewhat bearish rating.

Portfolio Pulse from Benzinga Insights

July 18, 2023 | 1:00 pm